Reynolds also discussed upcoming milestones including the preparing to launch its new product, Nu.Q™ Vet Cancer Screening Test for dogs, on November 30th.
VolitionRx Limited ends its 3Q with $21M in the bank, looks forward to upcoming product launches
Quick facts: VolitionRx
Price: 4.01 USD
Market Cap: $193.27 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of VolitionRx named herein, including the promotion by the Company of VolitionRx in any Content on the Site, the Company receives from said issuer...FOR OUR FULL DISCLAIMER CLICK HERE